Understanding Medicare Coverage for Semaglutide and Weight Loss
Medicare coverage for semaglutide is primarily limited to type 2 diabetes management. Coverage for weight loss alone is generally restricted and requires documented medical necessity. Understanding Medicare coverage for semaglutide helps clinicians…
Understanding Medicare GLP-1 Bridge Program Coverage
The Medicare GLP-1 bridge program coverage provides a pathway for beneficiaries transitioning between GLP-1 agents. This program helps prevent treatment interruptions and reduces out-of-pocket costs. Understanding eligibility criteria is essential for…
MMJ International Holdings Seeks Injunction to Halt CMS CBD Program | Newswire
MMJ International Holdings has filed for a cms cbd program injunction to block a Centers for Medicare and Medicaid Services initiative. This legal action raises critical questions about regulatory oversight of cannabidiol products in Medicare. The…
Are Seniors Being Used as CBD Guinea Pigs in CMS Program?
The 2026 cannabis clinical safety of seniors in CMS CBD programs is under scrutiny due to potential drug interactions and unique geriatric considerations. This emerging Medicare policy shift could impact older adults' access to cannabis medicine. Careful…
CMS Finalizes CY 2027 Medicare Advantage and Part D Rule | Insights | Holland & Knight
CMS has finalized the Medicare Advantage payment rate increase for 2027, a key update affecting healthcare access for over 65 million Americans. This change influences reimbursement policies and patient care options, including those related to cannabis…